glp 1 agonists vs sglt2 inhibitors GLP-1 Receptor Agonist Therapy With and Without in Patients With Type 2 Diabetes Metabolic Powerhouses: GLP-1 RAs and

Caron J, Domenger D, Dhulster P, Ravallec R, Cudennec B

Dispensing of glucagon-like peptide-1 receptor agonists to adolescents and young adults, 2020-2023

When caloric intake decreases, the body compensates by slowing metabolism and increasing hunger signals, making sustained weight loss difficult for many individuals

JAMA Netw Open 7(3):e243604 Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM et al (2022) Management of hyperglycaemia in type 2 diabetes, 2022

The connection remains investigational, and any effects on alcohol consumption should be considered preliminary findings requiring rigorous clinical validation

GLP-1 drugs such as Ozempic, Wegovy, and Zepbound have transformed obesity treatment, helping millions lose significant weight